BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8169000)

  • 1. Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide.
    Blackmore M; Doherty E; Manning JE; Hirst BH
    Int J Cancer; 1994 May; 57(3):385-91. PubMed ID: 8169000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.
    Blackmore M; Hirst BH
    Br J Cancer; 1992 Jul; 66(1):32-8. PubMed ID: 1637673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin--responsive human gastric adenocarcinoma cells in vitro.
    Piontek MK; Hengels KJ
    Anticancer Res; 1993; 13(3):715-20. PubMed ID: 8317902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gastrin, proglumide, loxiglumide and L-365,260 on growth of human colon carcinoma cells.
    Mauss S; Niederau C; Hengels KJ
    Anticancer Res; 1994; 14(1A):215-20. PubMed ID: 8166452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for autocrine growth stimulation by a gastrin/CCK-like peptide of the gastric cancer HGT-1 cell line.
    Remy-Heintz N; Perrier-Meissonnier S; Nonotte I; Laliberté MF; Chevillard C; Laboisse C; Bali JP
    Mol Cell Endocrinol; 1993 May; 93(1):23-9. PubMed ID: 8319831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of gastrin on human astrocytic tumor cell proliferation.
    Camby I; Salmon I; Danguy A; Pasteels JL; Brotchi J; Martinez J; Kiss R
    J Natl Cancer Inst; 1996 May; 88(9):594-600. PubMed ID: 8609660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCK/gastrin antagonists--clinical perspectives.
    Calam J
    Acta Gastroenterol Belg; 1993; 56(3-4):251-6. PubMed ID: 8266765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines.
    Hoosein NM; Kiener PA; Curry RC; Rovati LC; McGilbra DK; Brattain MG
    Cancer Res; 1988 Dec; 48(24 Pt 1):7179-83. PubMed ID: 3191491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin-B receptor ligands of the dipeptoid series act as agonists on rat stomach histidine decarboxylase.
    Ding XQ; Chen D; Håkanson R
    Gastroenterology; 1995 Oct; 109(4):1181-7. PubMed ID: 7557084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
    Staley J; Jensen RT; Moody TW
    Peptides; 1990; 11(5):1033-6. PubMed ID: 2178246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide.
    Watson SA; Morris DL; Durrant LG; Robertson JF; Hardcastle JD
    Eur J Cancer; 1992; 28A(8-9):1462-7. PubMed ID: 1355350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines.
    Ohlsson B; Fredäng N; Axelson J
    Scand J Gastroenterol; 1999 Dec; 34(12):1224-9. PubMed ID: 10636070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of gastrin as a growth peptide in human pancreatic cancer.
    Smith JP; Fantaskey AP; Liu G; Zagon IS
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R135-41. PubMed ID: 7840313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide.
    Hoosein NM; Kiener PA; Curry RC; Brattain MG
    Exp Cell Res; 1990 Jan; 186(1):15-21. PubMed ID: 2298233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct receptors for cholecystokinin and gastrin on canine fundic D-cells.
    DelValle J; Chiba T; Park J; Yamada T
    Am J Physiol; 1993 May; 264(5 Pt 1):G811-5. PubMed ID: 8098910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718.
    Thumwood CM; Hong J; Baldwin GS
    Exp Cell Res; 1991 Jan; 192(1):189-92. PubMed ID: 1984410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of cholecystokinin and its antagonists lorglumide, devazepide, and L-365,260 on gastrointestinal motility in rats].
    Wang SX
    Zhongguo Yao Li Xue Bao; 1993 Sep; 14(5):443-6. PubMed ID: 8010038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth-promoting effects of glycine-extended progastrin.
    Seva C; Dickinson CJ; Yamada T
    Science; 1994 Jul; 265(5170):410-2. PubMed ID: 8023165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O; Mennuni L; Revel L; Colombo S; Makovec F
    Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.